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Abstract: There are an estimated 35 million people with dementia across the world, of whom 
50% experience regular pain. Despite this, current assessment and treatment of pain in this patient 
group are inadequate. In addition to the discomfort and distress caused by pain, it is frequently 
the underlying cause of behavioral symptoms, which can lead to inappropriate treatment with 
antipsychotic medications. Pain also contributes to further complications in treatment and 
care. This review explores four key perspectives of pain management in dementia and makes 
recommendations for practice and research. The first perspective discussed is the considerable 
uncertainty within the literature on the impact of dementia neuropathology on pain perception 
and processing in Alzheimer’s disease and other dementias, where white matter lesions and 
brain atrophy appear to influence the neurobiology of pain. The second perspective considers 
the assessment of pain in dementia. This is challenging, particularly because of the limited 
capacity of self-report by these individuals, which means that assessment relies in large part 
on observational methods. A number of tools are available but the psychometric quality and 
clinical utility of these are uncertain. The evidence for efficient treatment (the third perspective) 
with analgesics is also limited, with few statistically well-powered trials. The most promising 
evidence supports the use of stepped treatment approaches, and indicates the benefit of pain 
and behavioral interventions on both these important symptoms. The fourth perspective debates 
further difficulties in pain management due to the lack of sufficient training and education for 
health care professionals at all levels, where evidence-based guidance is urgently needed. To 
address the current inadequate management of pain in dementia, a comprehensive approach is 
needed. This would include an accurate, validated assessment tool that is sensitive to different 
types of pain and therapeutic effects, supported by better training and support for care staff 
across all settings.
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Introduction
There are an estimated 35 million people with dementia across the world. Currently, 
5% of people over 65 years old have a diagnosis of dementia, rising to over 50% 
in those aged over 90 years.1 Demographic changes in the coming decades and the 
increasingly aging population will lead to a substantial growth in the number of people 
affected and in the scale of the challenge associated with providing treatment and care. 
Pain presents a particular challenge in the treatment of dementia. The prevalence of 
pain, particularly chronic pain, is strongly related to age, hitting the oldest population 
the hardest, with prevalence rates of 72% above the age of 85 years.2 Given these 
circumstances, it is clear that pain is probably very common among people with 
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dementia; nevertheless, current knowledge is poor, which 
frequently leads to inappropriate treatment and care.
“Dementia” is defined as a “clinical syndrome due to 
disease of the brain, usually of a progressive nature, which 
leads to disturbances of multiple higher cortical functions, 
including memory, thinking, orientation, comprehension, 
calculation, learning capacity, language, and judgment.”3 
The most common cause of dementia is Alzheimer’s disease 
(AD), but vascular dementia (VaD), frontotemporal dementia 
(FTD), and Lewy body dementia, are also  prevalent. In all 
subtypes of dementia, specific neuropathological changes 
are responsible for the decline in function. Besides the 
deleterious effects on cognition, the neuropathology of 
dementia is responsible for numerous other symptoms, 
such as behavioral disturbances, psychological problems, 
and the breakdown of language and communication. These 
problems have been summarized as “behavioral and psycho-
logical symptoms of dementia” (BPSD). Although memory 
dysfunction is the best-known symptom, BPSD, along with 
physical dysfunctions, have the highest impact on quality of 
life, and are one of the most important reasons for seeking 
help and institutionalization.4 Pain in dementia is also often 
expressed through behavioral disturbances. In fact, pain is 
thought to be one of the most important causal factors of 
BPSD.5 However, this causal link is often difficult to iden-
tify due to the complexities of BPSD, which change over 
the stages of dementia and are more frequent in the later 
stages of the disease.6 BPSD arising as a result of pain, such 
as agitation and aggression, can be extremely distressing 
for both the individual and their caregiver, and can lead to 
the inappropriate prescribing of antipsychotic medication 
instead of adequate pain treatment. While these medications 
do have their place in the treatment of severe or persistent 
psychiatric symptoms, they are associated with substantial 
side effects including increased mortality, cerebrovascular 
events, and falls.7,8
A further important and often forgotten issue is the 
impact of the neuropathological changes in dementia on pain 
perception.9 The symptomology of dementia also means that 
assessment of pain is particularly challenging due to the loss 
of communication ability, which usually occurs during the 
condition. As a result, commonly used assessment tools are 
neither valid nor reliable and are difficult to use. To com-
pound this, educational and organizational shortcomings in 
dementia care settings often hamper the quality of care and 
treatment, including management of pain.
This narrative review discusses the evidence from rel-
evant and recent literature regarding the challenges of pain 
management in dementia. The review focuses on four main 
perspectives that are critical to this discussion (Figure 1).
A literature search performed in PubMed (Medline) to 
supplement this review identified 1,669 publications relating 
to pain management in dementia. While the first mention of 
pain as a probable symptom in dementia appears in a pub-
lication in 1989,10 the first review was not published until 
1996,11 which indicates that scientific interest in this theme 
is relatively new.
Biological perspective:  
the effect and consequences  
of neuropathological changes  
in dementia on pain
Both neuropathological and neuroimaging studies have 
described interconnected brain areas that are important 
in the mediation of pain processing.9,11,12 Most studies 
describe two neuronal networks, the medial and lateral pain 
systems. The medial pain system – comprising the amygdala, 
medial thalamus, hippocampus, anterior cortex cinguli, and 
prefrontal cortex – is a pathway that mediates cognitive–
evaluative and motivational-affective aspects of pain. In 
addition, autonomic–endocrine aspects are also mediated 
by the medial system.9,13 The lateral pain system comprises, 
among others, the primary somato–sensoric areas and the 
lateral thalamic nuclei. The sensory–discriminative aspects 
(localization, intensity, and quality of pain) are mediated by 
the lateral pain system.9 Overlap of the two systems might 
occur in the insula. Recently, the existence of a third pathway 
mediating other critical aspects of pain has been proposed. 
This is thought to be a rostral, or limbic, pain system, which 
mediates behavioral aspects of pain – for example, agitated 
behavior as a reaction to pain.14
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Figure 1 A model of challenges in pain management in patients with dementia.
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Pain in AD
In AD, the distribution of neuropathological changes leads 
to a greater impact on the medial pain system than on the 
lateral system. This would imply that the cognitive- evaluative 
and motivational-affective aspects of pain are more greatly 
affected than the sensory-discriminative aspects.9 The clinical 
consequences for people with AD would be an unchanged 
pain threshold but a higher pain tolerance. Some experimental 
studies have indeed confirmed this theory.15,16 As would be 
expected following examination of the autonomic-endocrine 
aspects of the medial system and the changes in AD, blunted 
autonomic responses to pain have also been reported in 
experimental studies,16 although these responses are thought to 
remain active in cases of intense pain.17 Interestingly, however, 
more recent findings have shown that pain processing – as 
indicated by brain responses in electroencephalography and 
functional magnetic resonance imaging (fMRI) studies, pain 
reflexes, and facial responses to noxious stimuli – does not 
appear to be diminished in Alzheimer patients. Indeed, in 
some cases, it appears to be elevated.12,18 These findings 
emphasize the caution that must be taken when extrapolating 
outcomes of animal studies to humans.
The rostral pain system overlaps with several components 
of the medial and lateral pathways, with the exception of 
the ventral striatum, which is generally not seen as a part 
of these other pathways. The striatum is severely affected in 
AD. Based on fMRI findings, it is hypothesized that people 
with mild to moderate AD have a relatively increased acti-
vation of the striatum in response to pain.14 Conversely, this 
work indicates that there is a relatively decreased activation 
in severe AD. Behavioral changes in mild and moderate 
AD are therefore thought to be stronger, while in severe 
AD they might be normal or even blunted.14 In fact, some 
clinical studies have found less pain-related behavior in more 
severely cognitively impaired patients.19,20 Relatively strong 
associations have been shown between pain and depression, 
as well as unspecified behavioral problems.21,22 Associations 
of pain with agitation, aggression, delusions, wandering, and 
resistance to care have also been established, although the 
link is less consistent.23–26
In another fMRI study, a connectivity analysis was used 
to examine the impact of AD on the integrated function-
ing of brain regions mediating the sensory, emotional, and 
cognitive aspects of pain. Functional connectivity between 
the cortical and subcortical brain regions appeared enhanced 
in AD patients. Three functionally connected nodes were 
the right dorsolateral prefrontal cortex, hypothalamus, and 
periaqueductal gray, which tended to be constantly activated 
in the AD patients, who received repeated pain stimuli 
and could not reduce generalized brain activity.27 Another 
important aspect of the neuropathological change that occurs 
in the prefrontal lobe in people with AD is the alteration of 
response to analgesic medication. An experimental study 
showed that the endogenous expectation and placebo mecha-
nism, an important aspect of pain management, is reduced 
in people with AD. This effect is particularly pronounced 
where damage in the connectivity between the prefrontal 
lobes and the rest of the brain is extensive, or where frontal 
neuropsychological function, as tested by the Frontal Assess-
ment Battery, is significantly reduced.15 It is therefore likely 
that people with AD require a higher dosage of pain medi-
cation, to achieve the analgesic result that would normally 
be expected in a cognitively healthy adult. Further, there 
remains a great deal of uncertainty as to whether changes 
in the blood–brain barrier that occur during the dementia 
process might influence the effect of centrally acting pain 
medication such as morphine.28
Pain in other types of dementia
There have been few studies on pain in different subtypes of 
dementia such as VaD, FTD, or Lewy body dementia. In VaD, 
white matter lesions lead to several  disconnections between 
areas of the brain in a process known as “ deafferentiation.” 
This is thought to be responsible for an increase in the 
motivational–affective aspects of pain. This type of pain, 
also called “central neuropathic pain,” occurs frequently in 
patients who have had a stroke29 and there is some clinical 
evidence that this type of deafferentiation pain might also 
occur in VaD.17,30
In people with FTD, it is plausible that the atrophy in the 
prefrontal cortex that characterizes the condition leads to a 
decrease in the motivational–affective aspects of pain, in a 
similar way to AD. In one study, patients with FTD reported 
less pain than patients with AD following the same experimental 
pain stimulus.31 An underlying mechanism for this differential 
response may be due to the more extensive pathology in the pre-
frontal cortex in FTD compared with in AD. Previous reviews 
and literature consistently highlight the lack of differential evi-
dence around brain pathology and pain experience in different 
types of dementia.32 However, while this criticism is valid, it is 
important to note that most people with dementia have mixed 
pathologies. It is particularly common to encounter combina-
tions of gray matter atrophy and white matter lesions, and recent 
studies have shown that vascular damage, and, consequently, 
white matter lesions, is a prominent neuropathological char-
acteristic in AD. It is therefore perhaps less useful to consider 
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the specific pathologies of pain in different, yet overlapping, 
types of dementia, and more helpful to consider the locations 
within the brain that are affected.
Summary
There is conflicting evidence from neuropathological, neu-
roimaging, experimental, and clinical research regarding the 
impact of dementia neuropathology on pain processing and 
perception. One might speculate that atrophy of gray matter 
appears to lead to an increase in pain tolerance, while white 
matter lesions result in a decrease in tolerance. However, 
the consequences of the disturbed balance in excitatory and 
inhibitory processes in central nociception are still far from 
clear. These alterations in pain processing may have significant 
consequences for pain assessment and treatment, and should 
be considered when developing pain management approaches 
for use in dementia. Importantly, the direction of the impact of 
neuropathology may differ in subtypes of dementia, and even 
within individuals. There thus remains a great deal of uncer-
tainty regarding the effects of neuropathological changes in 
dementia. This lack of clarity likely contributes to indecision 
in practice and to inappropriate treatment choices.
Assessment perspective:  
the challenges of pain  
assessment in dementia
Accurate assessment of pain is a major prerequisite for 
adequate pain management and to assess the (positive) 
impact and potential adverse effects of analgesic medications. 
 Assessment of pain in people with dementia is particularly 
challenging due to the loss of communication ability inherent 
in the symptomology of the condition, which limits the subjec-
tive reporting of pain that would normally be expected with 
cognitively healthy adults. The examination of a patient in 
pain aims to clarify the causal and maintaining factors leading 
to pain, which may be somatic or psychic, or an interaction 
of both. The outcome of an examination may therefore be the 
identification of dominating sources or mechanisms of pain, 
like nociceptive (ie, musculoskeletal), visceral (ie, internal 
organs), neuropathic (ie, diabetic neuropathy), functional, or 
psychosomatic (ie, fibromyalgia) pain. Evidence indicates 
that around 60%–80% of people with dementia in care 
homes regularly experience pain, most commonly related to 
musculoskeletal, gastrointestinal and cardiac conditions; geni-
tourinary infections; and pressure ulcers.5 Orofacial pain is 
also of frequent occurrence.33 Different forms of pain  present 
 different challenges. Pain related to the internal organs, head, 
and skin is particularly challenging to detect compared with 
pain related to the musculoskeletal system, which can be 
identified through gentle guided movements.34 Acute pain, 
such as that following a fall or acute heart attack is easier to 
assess than chronic pain, which often provokes pain avoidance 
through reduced movement or relieving posture.
Assessment through self-report
In the earlier stages of dementia, when cognitive impairment 
is limited and communication ability is mostly intact, self-
report of pain is usually possible. There are several self-report 
scales, among which the Visual Analog Scale (VAS), the 
Numerical Rating Scale, and the Faces Pain Scale (FPS)5 
are the most frequently used. A study in 129 patients with 
severe dementia (mini-mental state examination score ,11), 
which aimed to assess the performance of self-assessment 
scales (the verbal-, visual-, and faces pain scales), found 
that 61% understood at least one scale;35 that is, they were 
able to explain the scale use and correctly indicate positions 
for no pain and extreme pain on two separate occasions. 
 However, the study found that participants had difficulty 
using the FPS, which is perhaps less useful, even in earlier 
stages of dementia.36 The “matching of a line length” to the 
intensity of pain, as required by the VAS, has also been shown 
to be challenging for people with cognitive impairment. 
Therefore, simple verbal or numerical categorical scales are 
recommended. As the neuropathological damage progresses, 
assessment by self-report becomes more difficult.
In more advanced stages of dementia, the majority of 
individuals are no longer able to give valid self-reports. In 
addition to their loss of communication, people are often no 
longer able to use introspection to gain knowledge about pain, 
are unable to report or anticipate its onset and duration, and 
are unable to understand questions related to the evaluation of 
their pain.37 In these individuals, self-report is not an option, 
and a proxy rater, usually a primary caregiver, who knows 
the patient and their usual behavior, should be included in 
pain assessment. However, it should be noted that one should 
always make an effort to obtain some sort of self-report within 
the limitations of the individual’s symptoms and condition.
Assessment through observation  
of behavior
Where self-report is not possible, observation and detection of 
pain-related behavior is a valuable approach to identification 
of pain in dementia. An expert panel convened by the 
 American Geriatrics Society (AGS) published guidance 
outlining the various behavioral expressions of pain in the 
elderly, including facial expressions, body movements and 
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vocalizations, which are helpful when developing assessment 
tools for dementia (Table 1).38 Facial expressions are particu-
larly useful in detecting discomfort in AD.39,40 Interestingly, 
sensory and affective components of pain can be differen-
tially expressed in the face, with sensory aspects shown by 
movements around the eyes, and affective aspects depicted 
by movements of the eyebrows and the upper lip.41 However, 
it should be noted that the accurate application of the method 
of reading facial expressions using the Facial Acting Coding 
System requires comprehensive training, which may make 
this approach unfeasible in clinical practice.42
Several observational scales have been developed based 
on the presence or alteration of the behaviors, emotions, 
interactions, and facial expressions described by the AGS 
Panel. Several review articles discuss the psychometric 
properties of these instruments and their use in clinical 
practice.5,33,42–47 A common conclusion of the current body of 
literature is that there are a number of promising pain assess-
ment instruments available but that most of these require 
further validation in people with dementia and assessment 
of their utility in clinical settings. Other weaknesses of many 
of the existing instruments are that the distinction between 
chronic and acute pain is rarely considered; validity studies 
in several situations where pain might arise, such as at rest, 
during day-to-day activities, and during guided movements, 
are often lacking; and it is unclear if different types of 
pain  (nociceptive, neuropathic, visceral) can be addressed. 
 Further, specific conditions such as orofacial pain have been 
almost completely overlooked.33 Given the elevated level 
of facial response to pain stimuli in people with dementia 
compared with in cognitively healthy older adults, this is a 
key omission in the existing tools.18
Assessment of neuropathic pain
Neuropathic pain is often based on underlying diseases such 
as diabetic neuropathy, after stroke and amputation. Assessing 
this form of pain in dementia is extremely challenging. The 
assessment of “central neuropathic pain,” which is defined 
as pain caused by a lesion, or dysfunction of the central 
nervous system, is even more complex.48 Approximately 
35% of stroke patients suffer from post-stroke central 
neuropathic pain.29 Because this deafferentiation also takes 
place in VaD, it has been suggested that central neuropathic 
pain is by far the most undertreated type of pain in patients 
with dementia.49 The assessment and treatment of this type 
of pain is of high clinical relevance, but it has hardly been 
described in the literature, most likely because it requires 
assessment and treatment approaches that differ from those 
of other types of pain. In 2004, the European Federation of 
Neurological Societies (EFNS) Panel on Neuropathic Pain 
published guidelines on neuropathic pain assessment that 
included thorough sensory bedside testing in individuals with 
neuropathic pain.50 This guidance would provide a useful 
basis for an assessment tool for neuropathic pain. However, 
as far as the authors are aware, no such instrument has been 
developed to date.
Organizational and educational 
aspects that challenge pain 
management in dementia
The challenges inherent in the assessment of pain in people 
with dementia, due to both symptomology and neuropa-
thology, mean that health care workers are not sufficiently 
prepared to handle the difficulties in establishing good 
pain management practice for these patients. The literature 
suggests that a large proportion of these issues could be 
overcome through better education on specific aspects of 
pain management and through more effective facilitation 
of pain assessment within organizations. It has long been 
established that inaccurate beliefs and poor knowledge 
Table 1 Common pain behaviors in cognitively impaired elderly 
persons according to the AGS Panel on persistent pain in older 
persons38
1. Facial expressions Slight frown; sad, frightened face 
Grimacing, wrinkled forehead 
Closed or tightened eyes 
Any distorted expression 
Rapid blinking
2.  verbalizations,  
vocalizations
Sighing, moaning, groaning 
Grunting, chanting, calling out 
Noisy breathing 
Asking for help 
verbally abusive
3.  Body movements Rigid, tense body posture, guarding 
Fidgeting 
Increased pacing, rocking 
Restricted movement 
Gait or mobility changes
4.  Changes in interpersonal  
interactions
Aggressive, combative, resisting care 
Decreased social interactions 
Socially inappropriate, disruptive 
withdrawn
5.  Changes in activity  
patterns or routines
Refusing food, appetite change 
Increase in rest periods 
Sleep, rest pattern changes 
Sudden cessation of common routines 
Increased wandering
6.  Mental status changes Crying or tears 
Increased confusion 
Irritability or distress
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and training of staff and management in long-term care are 
important barriers to high quality care. Even experienced 
staff would be expected to benefit from specific education 
and training in pain assessment, pharmacological treatment, 
pain neurophysiology, and non-pharmacological treatments. 
A major educational goal is to improve their competency 
in distinguishing pain behaviors from other behavioral 
 symptoms.51 Managers in long-term care are often unaware 
of the best ways to manage pain in people with dementia. 
Many do not base decisions on evidence-based guidelines 
and often hold outdated beliefs regarding the use of treatment 
options (eg, opioid analgesics).52 Good-quality training is 
essential to address this. One recent study showed that after 
three interactive 3-hour sessions, gaps in staff knowledge 
of pain management were reduced and pain management 
strategies were put into practice four times more frequently 
than after the control intervention.53 A controlled pre-post 
design trial studied the implementation of a pain protocol 
with a multifaceted approach. Next to skills training and edu-
cation, this included a pain team and other quality improve-
ment  activities. Both quantitative and qualitative evaluation 
showed that this intervention was successful.54
Recommendations to improve pain assessment and man-
agement in nursing homes, including national guidelines, 
have stressed the importance of a well-trained, knowledge-
able pain team.55,56 In addition, implementation of treatment 
algorithms and consultation, continuous education, and team 
building within the care team are seen as the cornerstones of 
better pain management (Table 2).56 A Canadian study that 
consulted frontline staff and administrators in long-term care 
revealed overall a general attitude that is open to change in 
which staff acknowledged the need for better implementation 
of pain management. Stakeholders identified a number of bar-
riers including a lack of resources and lack of support from 
funding bodies. Free evidence-based tools and best practices 
for nurses, who work in nursing homes, are available through 
www.geriatricpain.org. However, it is clear that to elicit 
change in practice it will be key to position an accountable 
professional or onsite leader to champion implementation of 
better care standards.57
Use of evidence-based observational assessment instru-
ments has often been advocated for regular practice.44,55,58 
Although there is considerable room for improvement in 
existing instruments, their use is certainly still recom-
mended and can support better and more timely treatment 
of pain, particularly when self-report is not possible. A 
critical step in improving pain management is the promo-
tion and implementation of these existing tools. Current 
uptake and use of instruments is low, and in some cases 
appears nonexistent. For example, a recent study in acute 
care settings in Finland showed very low use of pain 
instruments following hip fracture surgery. When an instru-
ment was used, it was usually the VAS, which is known to 
provide unreliable information in people with dementia.59 
Compliance in the use of these observational instruments 
in long-term care settings has also been disappointing. It 
is important to emphasize that while implementation of 
these observational scales is an important step to improve 
pain management, this alone will not necessarily mean that 
treatment will be improved. Key evidence and guidance are 
needed to support the decision-making process to translate 
a pain score to treatment. This is a complex process, as 
a recent Dutch study has shown,60,61 and several studies 
emphasize that recognition of the pain does not necessarily 
lead to appropriate treatment.62–66
Pain management in practice
Some studies have suggested that pain is less prevalent 
in patients with dementia because they suffer from less 
comorbidity,67 although several other studies have found that 
people with dementia do not have less painful conditions.68,69 
Taken together, the literature indicates that about 50% of 
patients with dementia are regularly in pain.5 The largest 
study, which included over 5,000 home-care patients, also 
found no difference in pain prevalence in patients with or 
without dementia.70
Table 2 Recommendations to improve pain assessment and 
management in nursing homes56
1.  Include an initial needs assessment of current pain care practices, 
formation of a pain quality improvement team guided by a systematic 
implementation process model, identification of clear quality 
indicators, and an ongoing educational component
2.  Use evidenced-based clinical decision-making algorithms for assessing 
and treating pain in persons with dementia
3.  Collaboratively engage all members of the care team, including 
residents, nurses at all levels within the organization, prescribers, 
medical directors, direct care workers, pharmacists, and families 
when considering pain care process changes
4.  Specifically target team-building with a goal of facilitating 
improvements in communication between prescribers and nurses 
about pain care in particular
5.  Incorporate a plan for regular periodic evaluation of pain management 
processes (eg, documentation of pain assessments and administration 
of analgesic medications on a scheduled basis) and resident outcomes, 
particularly pain severity and satisfaction, into efforts to ensure 
ongoing implementation of new practices
6.  Use consultants with expertise in pain management and process 
improvement strategies for on-site consultation
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Pain in people with VaD has received little attention in 
research. One of the few studies shows that, in line with the 
theory based on the neuropathological changes, more spe-
cifically white matter lesions, people with possible VaD may 
experience an increase in the experience of the motivational-
affective aspects of pain.71 Cross-sectional analyses in people 
with dementia living in nursing homes have demonstrated 
that there is a particular risk of severe pain in people with 
severe dementia and a mixed form of dementia (ADVaD) due 
to the restricted use of pain medication.72 Those with ADVaD 
receiving opioids as pain treatment tended to have higher pain 
intensity than people without dementia receiving the same 
treatment. In addition, ADVaD patients have a significantly 
higher frequency of International Statistical Classification 
of Diseases and Related Health Problems 10th Revision 
(ICD-10) diagnoses and are therefore suggested to be more 
vulnerable. As a consequence, they may have a lower toler-
ance for opioids. The evidence thus supports the importance 
of particular caution by physicians when prescribing opioids 
in people with ADVaD.
International epidemiological research has shown that the 
elderly in general, but especially those with dementia, receive 
less pain medication than their cognitively healthy counter-
parts, even in the same painful situations – for example, after 
a hip fracture.73 The low dosage of pain medication seems to 
occur consistently in residential, nursing home, and hospital 
care.63,74–77 Remarkably, recently, a few studies have reported 
a possible overuse of analgesics, particularly paracetamol, in 
patients with dementia,68,78,79 stressing the clinical  difficulties 
and uncertainties in the assessment of pain in these indi-
viduals (Figure 2). However, when people with dementia 
are prescribed pain medication, it is generally of low dosage 
and stronger pain medication such as opioids, are less likely 
to be considered.5 For instance, patients with a hip fracture 
who have dementia receive significantly less opioids, both 
pre- and post-surgery. Where opioids are prescribed, they are 
used at a dosage that is one-third of that used in cognitively 
intact persons.73
The insufficient management of pain in patients with 
dementia can be explained by several factors. This uncertainty 
is partly due to the scarcity of pharmacological studies, which 
limits understanding of the pharmacodynamics of analgesic 
medication in this group of people.80 The optimal treatment 
in these patients is therefore predominantly experience based. 
Clinicians must make decisions on type and dosage of anal-
gesia without clear knowledge of the impact of the cognitive 
comorbidity of their patient. This lack of knowledge extends 
among the range of health professionals who work with 
people with dementia, including nurses and pharmacists.81 
It is likely that this results in both under- and overtreatment. 
Efficacy studies of analgesics in patients with dementia are 
challenging but feasible and there is an urgent need for more 
research in this area.82
The fact that pain is often expressed through challeng-
ing behavior, particularly in advanced dementia, has led to 
several studies investigating the benefit of interventions for 
both pain and behavior on reducing behavioral symptoms 
as a proxy measure for pain. Available evidence suggests 
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Figure 2 Studies on the prevalence (in %) of analgesic use in patients with dementia compared with in cognitively unimpaired patients (no dementia).
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that pain interventions targeting behavioral disturbances 
and behavioral interventions targeting pain are effec-
tive in  reducing both pain and behavioral symptoms in 
dementia.83 Since 2003, five randomized controlled trials 
(RCTs) have investigated the treatment effect on pain 
intensity or behavioral disturbances in these individuals. 
Manfredi et al evaluated the effect of opioid analgesics 
on behavioral disturbances in 25 patients with agitation 
assessed by Cohen-Mansfield Agitation Inventory.84 Of 
the 25 subjects, 13 aged over 85 years showed significant 
reduction of agitation after 4 weeks. In another 4-week 
placebo-controlled crossover study, 39 patients with pain 
received regular paracetamol.85 Pain was assessed using 
the Discomfort Scale for Dementia of the Alzheimer’s 
Type. No significant differences in pain scores were found 
in the intervention group. However, the paracetamol dos-
age was low and might have been insufficient to have a 
therapeutic effect. In a placebo-controlled crossover trial 
with 25 patients, Chibnall et al investigated the efficacy 
of paracetamol on emotional well-being and behavior 
assessed by Dementia Care Mapping and Cohen-Mansfield 
Agitation Inventory, respectively.86 The study reported 
significant improvement in activities but found no effect on 
agitation. In the fourth study, 114 patients with behavioral 
disturbances were assigned randomly to either a serial trial 
intervention (STI) of stepped assessment and treatment 
or usual care. Patients randomized to the STI underwent 
non-pharmacological comfort intervention. Those still in 
pain after this treatment (n = 26) received analgesics. Pain 
was assessed using the Discomfort Scale for Dementia 
of the Alzheimer’s Type and behavioral  disturbances by 
the Behavioral Pathology in Alzheimer’s Disease Scale.87 
Results indicate that the STI approach improved behav-
ioral symptoms significantly, but the effect of analgesics 
is not reported.
It is clear that most of these studies were underpow-
ered with small sample sizes, were restricted to the use 
of paracetamol or opioids, and lacked validated outcome 
measures of pain.83 The most striking study, an RCT in 
nursing home patients with dementia and high levels of 
behavioral symptoms, showed a significant relationship 
between improvement in agitation and improvement in 
pain, suggesting that better pain management was the main 
therapeutic factor. In addition, agitation worsened when the 
analgesia was discontinued, even though the study continued 
for only another 4 weeks.88 The vast majority of participants 
in the pain treatment group received only paracetamol, so 
it is unlikely that the effect was merely due to nonspecific 
sedation from stronger analgesics. Secondary analyses found 
that verbal agitation behaviors such as complaining, negativ-
ism, repetitious sentences and questions, constant request 
for attention, and cursing or verbal aggression responded 
to pain treatment. In addition,  restlessness and pacing were 
sensitive to analgesics.89
evaluation of pain management: 
responsiveness
The assessment of pain is the prerequisite for appropriate 
pain treatment. To provide effective treatment, it is also 
essential to identify when a treatment response is present. 
To enable this, there is an urgent need for a pain assessment 
instrument that can detect changes in pain intensity following 
treatment. As stated by Cohen-Mansfield and Jensen,90 the 
utility of a pain assessment tool lies in its ability to identify 
persons whose manifestation of pain will decrease after 
receiving pain treatment. “Responsiveness” has recently been 
defined as “the ability of an instrument to detect change over 
time in the construct to be measured.”91 As pain is a subjec-
tive experience, this measurement requirement is difficult 
to document in patients with dementia and therefore merits 
particular attention during development of pain assessment 
tools. To date, as far as the authors are aware, only two studies 
have investigated the responsiveness of pain  assessment 
instruments for patients with dementia and nonverbally com-
municating elderly people.92,93 Cohen-Mansfield and Jensen 
compared the responsiveness of 12 self-report, informant 
rating, and observational instruments to pain treatment with 
non-opioids and opioids. Most sensitive to the effect of treat-
ment were the Pain Assessment for the Dementing Elderly 
and Pain Assessment Instrument in Noncommunicative 
Elderly tools. Another subsequent trial of pain treatment 
in nonverbally communicating elderly reported very good 
responsiveness of the Elderly Pain Caring Assessment 2 tool 
after the pain treatment with non-opioids of 32 participants 
with dementia.93
To perform valid responsiveness studies, RCTs with 
appropriate sample sizes are a prerequisite, but most of 
the current controlled studies did not include a representa-
tive sample of elderly with dementia.5 Further, it is vital 
that the final evaluation of the psychometric qualities of a 
scale considers the criterion of responsiveness against the 
criterion of reliability. Focusing only on the volatile and 
state-like aspects of pain (eg, transient facial responses) in 
an instrument may increase its responsiveness, because every 
change is detected, but may neglect resistant and trait-like 
pain features (eg, ongoing relieving posture). The result 
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might be a premature “all-clear” when pain has not been 
fully addressed.
Discussion
The evidence presented in this review on pain manage-
ment in people with dementia demonstrates the severe lack 
of effective assessment and treatment across the range of 
clinical settings. Pain is common among the elderly due 
to the increased prevalence of age-related conditions like 
osteoporosis, arthritis, and cardiovascular disease, and this is 
also true for people with dementia. These individuals appear 
to experience the intensity and affective component of pain 
differently than their cognitively intact counterparts do. In 
addition, the loss of communication ability leads to serious 
difficulties in detecting pain, particularly in more severe 
stages of dementia. In these individuals, pain is often also 
expressed in specific behaviors, such as agitation or with-
drawal, that might mimic psychiatric conditions.
The etiology of these BPSD is multifactorial, and 
includes the neuropathological changes in the brain related to 
 dementia, but also unmet physical and psychological needs, 
physical illnesses like urinary tract infections, and pain. In 
many cases, this results in the inappropriate treatment of 
behavior with antipsychotic medication. Several studies 
have shown that treatment of pain might indeed decrease 
these behavioral symptoms. It is therefore of critical impor-
tance to improve the recognition and assessment of pain to 
ensure that patients receive the most appropriate treatment.
One of the main issues in this process is the develop-
ment of an assessment toolkit that has good psychometric 
characteristics, can be used in different types of patients 
with cognitive impairment, is available in many languages, 
is sensitive to change, is easy to use in different settings, and 
is feasible and practical for nurses and other users. This task 
has been taken up in the European Cooperation in Science and 
Technology’s (COST) action, “Pain assessment in patients 
with impaired cognition, especially dementia,” which started 
in 2011. This 4-year initiative combines the knowledge of 
experimental and clinical researchers with that of clinical 
experts with the goal of reducing the fragmentation in inter-
national research and striving for international cooperation, 
bringing together leading researchers from a wide range of 
scientific disciplines. The major aim is the development of 
a comprehensive and internationally agreed-on assessment 
toolkit for older adults, targeting the various subtypes of 
dementia (see also COST).94
Alongside this work, it is essential that implementa-
tion and continuous education and training programs be 
developed, implemented, and evaluated to ensure the  effective 
use of any new tool. These are prerogative steps for better 
management, but this will not follow automatically. There is 
a great need to provide support and clear guidance for clini-
cians and other health professionals, such as pharmacists and 
nurses who are involved in the treatment and care of people 
with dementia, to enable them to make informed decisions, 
and to remove the current reluctance to prescribe effective 
analgesia for people with dementia. The further introduction 
of established “pain teams” and opportunities for staff to 
consult with experts in all dementia care settings to come to 
collaborative decisions will also be potentially valuable in 
ensuring future improvements in the effective management 
of pain in dementia.
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